Categories: New Launches

Novo Nordisk Global Business Services launches safe pharmaceuticals disposal initiative for employees

Bangalore, September 20, 2024: Novo Nordisk Global Business Services (GBS) announced the launch of a sustainable initiative called Eco Med Safe aimed at promoting safe and responsible disposal of pharmaceutical products, on World Patient Safety Day, in partnership with Connect and Heal Foundation. Launched internally for employees, this unique program is designed to minimise environmental impact and enhance public health by safely disposing unused or expired medicines. 

The comprehensive eco-pharmacovigilance initiative is a pivotal step towards Novo Nordisk’s commitment to minimise environmental impact and maximise our positive impact on public health.

“Through this program, we aim to address the significant environmental risks posed by improper disposal of medications. The safe removal of expired or unused pharmaceuticals prevents contamination of water systems and soil, protecting both ecosystems, human and animal health. This initiative is also likely to contribute to mitigating the development of antibiotic-resistant bacteria which is a growing global concern linked to the presence of antibiotics in the environment,” shared Dr. Prasanna Kumar T. S. Vice President, Global Safety, Novo Nordisk Global Business Services. 

“Building on our Circular for Zero environmental strategy, we view the Sustainable Development Goals (good health & sustainable communities) as a great opportunity to enhance our sustainability efforts. The Eco Med Safe program presents an innovative educational platform, promoting responsible medication disposal practices and significantly reducing environmental risks. Education is essential for achieving success in this endeavor, and we are enthusiastic about partnering with other companies and the broader healthcare community. Together, we can better understand the impacts of improper disposal of unused medicines and support voluntary community collection programs,” said John Dawber, Corporate Vice President & Managing Director, Novo Nordisk Global Business Services.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

MediBuddy Introduces All-in-One Digital Health Solution with MediBuddy Shield and MediBuddy Shield Plus Wellness Cards

Mumbai, September 20, 2024: MediBuddy, India’s largest digital healthcare platform, announced the launch of its…

10 hours ago

Fortis Bannerghatta Road Pioneers India’s First Robotic-Assisted Breast Reconstruction Using Natural Tissue on a Breast Cancer Patient

Bangalore, September 19, 2024: Minimal Access Surgical Oncology Team at Fortis Hospital Bannerghatta Road achieved…

1 day ago

Bharat Serums and Vaccines LtdLaunches Project Janani To Empower and Educate Women on Effective Breastfeeding Practices

Partners with ARTIST Academy to provide training to primary healthcare providers Mumbai, September 19, 2024:…

1 day ago

City Imaging Responds to a Call for Early Screening of Liver Diseases with Launch and Extension of FibroScan6

“Every third Indian has fatty liver, which often predates Type 2 diabetes and other metabolic…

2 days ago

Ankura Hospital Successfully saves a three-month-old baby

Removes a safety pin from the stomach lining through the minimal invasive technique of Endoscopy…

3 days ago

51-year-old woman successfully treated for thoracic aortic aneurysm using minimally invasive TEVAR surgery at Apex Group of Hospitals

Mumbai, September 17, 2024: 51-year-old woman Mrs. Swati Pandit (name changed) from Dahisar started complaining of…

3 days ago